Be The First to Receive Breaking News
ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer
ITUS to Ring the NASDAQ Closing Bell on July 5th
ITUS Accelerates Schedule for its CAR T Therapy and Provides Update
Cancer Fact: Stomach cancer accounts for 6.8% of worldwide cancer incidences.